Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins-Reference-Cited by-同舟云学术

Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins

Published:2000-02 Issue:2 Volume:36 Page:136-144
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Boulland ,Wechsler ,Bagot ,Pulford ,Kanavaros ,Gaulard

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2559.2000.00799.x/fullpdf

Reference42 articles.

1. Mycosis fungoides and Sezary syndrome;Diamandidou;Blood,1996

2. Primary cutaneous CD30+ large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis;Beljaards;Cancer,1993

3. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer;Willemze;Blood,1997

4. Lymphomatoid papulosis: a continuing self healing eruption, clinically benign − histologically malignant;Macaulay;Arch. Dermatol.,1968

5. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins;Kummer;J. Immunol. Methods,1993

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates;Human Pathology;2023-10

2. デュピルマブ（デュピクセント<sup>®</sup>）投与中に発症した CD30 陽性 T 細胞リンパ増殖症の 1 例;The Nishinihon Journal of Dermatology;2023-10-01

3. Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates;Human Pathology;2023-08

4. Lymphomatoid Papulosis “Type E” Affecting the Palate: A Detailed Case Report and Review of Literature;The American Journal of Dermatopathology;2023-03-20

5. Indolente kutane T-Zell-Lymphome;Indolente Lymphome;2023